SCOPUS 정보 검색 플랫폼

European Journal of Haematology

Volumn 76, Issue 4, 2006, Pages 358-359

Thalidomide for the treatment of leptomeningeal multiple myeloma

(6) Hattori, Yutaka a Yabe, Mariko a Okamoto, Shinichiro a Morita, Kunihiko a Tanigawara, Yusuke a Ikeda, Yasuo a

a KEIO UNIVERSITY SCHOOL OF MEDICINE (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; METHOTREXATE; PREDNISOLONE; THALIDOMIDE; VINCRISTINE;

ADULT; BONE MARROW EXAMINATION; BONE PAIN; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; FEMALE; HERPES ZOSTER; HUMAN; LEPTOMENINX; LETTER; MONOTHERAPY; MULTIPLE MYELOMA; NEUROLOGIC EXAMINATION; NEUTROPENIA; PLASMACYTOMA; PRIORITY JOURNAL; REMISSION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; ETOPOSIDE; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOGLOBULIN G; MELPHALAN; MENINGEAL NEOPLASMS; MIDDLE AGED; MULTIPLE MYELOMA; NITROSOUREA COMPOUNDS; PREDNISOLONE; PREDNISONE; THALIDOMIDE; VINDESINE;

EID: 33644839764 PISSN: 09024441 EISSN: 16000609 Source Type: Journal
DOI: 10.1111/j.1600-0609.2005.00591.x Document Type: Letter

Times cited : (23)

References (4)

1
- 0036223725
- Myeloma of the central nervous system: Association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations
- F assas AB M uwalla F B erryman T et al. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations Br J Haematol 2002 17 103 108
- (2002) Br J Haematol , vol.17 , pp. 103-108
- Fassas, A.B.¹ Muwalla, F.² Berryman, T.³

2
- 0035670407
- Meningeal and cerebral involvement in multiple myeloma patients
- P atriarca F Z aja F S ilvestri F S perotto A S calise A G igli G F anin R. Meningeal and cerebral involvement in multiple myeloma patients Ann Hematol 2001 80 758 762
- (2001) Ann Hematol , vol.80 , pp. 758-762
- Patriarca, F.¹ Zaja, F.² Silvestri, F.³ Sperotto, A.⁴ Scalise, A.⁵ Gigli, G.⁶ Fanin, R.⁷

3
- 0037799310
- Can thalidomide be effective to treat plasma cell leptomeningeal infiltration
- V icari P R ibas C S ampaio M A rantes AM Y amamoto M F ilho JBR S egreto RA B ordin JO C olleoni GWB. Can thalidomide be effective to treat plasma cell leptomeningeal infiltration Eur J Haematol 2003 70 198 199
- (2003) Eur J Haematol , vol.70 , pp. 198-199
- Vicari, P.¹ Ribas, C.² Sampaio, M.³ Arantes, A.M.⁴ Yamamoto, M.⁵ Filho, J.B.R.⁶ Segreto, R.A.⁷ Bordin, J.O.⁸ Colleoni, G.W.B.⁹

4
- 0036748453
- Et al. Thalidomide for the treatment of refractory multiple myeloma: Association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome
- K akimoto T H attori Y O kamoto S et al. Thalidomide for the treatment of refractory multiple myeloma: association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome Jpn J Cancer Res 2002 93 1029 1036
- (2002) Jpn J Cancer Res , vol.93 , pp. 1029-1036
- Kakimoto, T.¹ Hattori, Y.² Okamoto, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.